Xiayun Jin

Jinhua, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

USP13 stabilizes SOCS1 to reverse αPD-1 resistance in MSI-H colorectal cancer.

USP13 stabilizes SOCS1 to reverse αPD-1 resistance in MSI-H colorectal cancer.

Journal: Oncogene

Published: September 14, 2025

LCA, a bacterial metabolite, induces ferroptosis and senescence in triple-negative breast cancer.

LCA, a bacterial metabolite, induces ferroptosis and senescence in triple-negative breast cancer.

Journal: Toxicon : official journal of the International Society on Toxinology

Published: March 09, 2025

Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma.

Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: April 11, 2023

Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma.

Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma.

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Published: December 29, 2022

Retrospective analysis of the impact of dose delay and reduction on outcomes of colorectal cancer patients treated with FOLFIRI‑based treatment.

Retrospective analysis of the impact of dose delay and reduction on outcomes of colorectal cancer patients treated with FOLFIRI‑based treatment.

Journal: PeerJ

Published: November 08, 2022

Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.

Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.

Journal: BMC medicine

Published: October 26, 2022

An R-Based Landscape Validation of a Competing Risk Model.

An R-Based Landscape Validation of a Competing Risk Model.

Journal: Journal of visualized experiments : JoVE

Published: October 03, 2022

The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.

The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.

Journal: PloS one

Published: September 13, 2022

The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China.

The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China.

Journal: Scientific reports

Published: August 14, 2022

A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors.

A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors.

Journal: International journal of general medicine

Published: August 02, 2022

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer.

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer.

Journal: International journal of clinical oncology

Published: June 30, 2021

A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.

A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.

Journal: OncoTargets and therapy

Published: October 15, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026